39 related articles for article (PubMed ID: 35384600)
1. Association of polycystic ovary syndrome with atopic dermatitis: a case control study.
Kim IH; Andrade LF; Haq Z; Abdi P; Diaz MJ; Bray FN
Arch Dermatol Res; 2024 May; 316(6):258. PubMed ID: 38795196
[No Abstract] [Full Text] [Related]
2. Can the Total Thrombus-formation Analysis System (T‑TAS) better predict coagulation disorders than conventional laboratory measurements in patients with polycystic ovary syndrome?
Ożegowska K; Mantaj U; Rojewska P; Osiński M; Pawelczyk L; Kędzia M
Pol Arch Intern Med; 2020 Dec; 130(12):1114-1117. PubMed ID: 33016685
[No Abstract] [Full Text] [Related]
3. Comment on the grouping of patients with polycystic ovary syndrome based on body mass index.
Wei J
Hum Reprod; 2021 Dec; 37(1):193. PubMed ID: 34791247
[No Abstract] [Full Text] [Related]
4. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity C-reactive protein is a marker of obesity and not of polycystic ovary syndrome per se.
Gowri V; Rizvi SG; Squib S; Al Futaisi A
Fertil Steril; 2010 Dec; 94(7):2832-4. PubMed ID: 20561613
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of common mental disorders in women with polycystic ovary syndrome and its relationship with body mass index.
Rodrigues CE; Ferreira Lde L; Jansen K; Lopez MR; Drews Júnior CR; Souza LD
Rev Bras Ginecol Obstet; 2012 Oct; 34(10):442-6. PubMed ID: 23288220
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of macroprolactinemia in 259 women under investigation for polycystic ovary syndrome.
Hayashida SA; Marcondes JA; Soares JM; Rocha MP; Barcellos CR; Kobayashi NK; Baracat EC; Maciel GA
Clin Endocrinol (Oxf); 2014 Apr; 80(4):616-8. PubMed ID: 23758202
[No Abstract] [Full Text] [Related]
8. An unusual case report of polycystic ovary syndrome.
Muscogiuri G; Docimo A; Colao A
J Endocrinol Invest; 2022 Jul; 45(7):1459-1460. PubMed ID: 35384600
[No Abstract] [Full Text] [Related]
9. [Endocrinology 2007].
Lehnert H
Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1420-3. PubMed ID: 17570095
[No Abstract] [Full Text] [Related]
10. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
Talbott EO; Zborowskii JV; Boudraux MY
Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
[TBL] [Abstract][Full Text] [Related]
11. Tackling polycystic ovary syndrome.
Drug Ther Bull; 2001 Jan; 39(1):1-5. PubMed ID: 11221187
[TBL] [Abstract][Full Text] [Related]
12. Need for liver evaluation in polycystic ovary syndrome.
Carmina E
J Hepatol; 2007 Sep; 47(3):313-5. PubMed ID: 17624467
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
